Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9725389rdf:typepubmed:Citationlld:pubmed
pubmed-article:9725389lifeskim:mentionsumls-concept:C0010055lld:lifeskim
pubmed-article:9725389lifeskim:mentionsumls-concept:C0016004lld:lifeskim
pubmed-article:9725389lifeskim:mentionsumls-concept:C0439859lld:lifeskim
pubmed-article:9725389lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:9725389lifeskim:mentionsumls-concept:C1527362lld:lifeskim
pubmed-article:9725389lifeskim:mentionsumls-concept:C0439611lld:lifeskim
pubmed-article:9725389lifeskim:mentionsumls-concept:C0439608lld:lifeskim
pubmed-article:9725389pubmed:issue2lld:pubmed
pubmed-article:9725389pubmed:dateCreated1998-9-11lld:pubmed
pubmed-article:9725389pubmed:abstractTextThe Vivostat System is a medical device for the preparation of an autologous fibrin sealant from 120 mL of the patient's blood in the operating room. The system is fully automated and microprocessor controlled and is made up of three components: an automated processor unit, an automated applicator unit, and a disposable, single-patient-use unit, which includes a preparation set and a Spraypen applicator. The biochemical process is initiated by batroxobin, which acts upon the fibrinogen in the patient's plasma. The completion of the process depends entirely on endogenous thrombin in producing the sealant.lld:pubmed
pubmed-article:9725389pubmed:languageenglld:pubmed
pubmed-article:9725389pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9725389pubmed:citationSubsetAIMlld:pubmed
pubmed-article:9725389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9725389pubmed:statusMEDLINElld:pubmed
pubmed-article:9725389pubmed:monthAuglld:pubmed
pubmed-article:9725389pubmed:issn0003-4975lld:pubmed
pubmed-article:9725389pubmed:authorpubmed-author:TrumbullH RHRlld:pubmed
pubmed-article:9725389pubmed:authorpubmed-author:KjaergardH...lld:pubmed
pubmed-article:9725389pubmed:issnTypePrintlld:pubmed
pubmed-article:9725389pubmed:volume66lld:pubmed
pubmed-article:9725389pubmed:ownerNLMlld:pubmed
pubmed-article:9725389pubmed:authorsCompleteYlld:pubmed
pubmed-article:9725389pubmed:pagination482-6lld:pubmed
pubmed-article:9725389pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9725389pubmed:meshHeadingpubmed-meshheading:9725389-...lld:pubmed
pubmed-article:9725389pubmed:meshHeadingpubmed-meshheading:9725389-...lld:pubmed
pubmed-article:9725389pubmed:meshHeadingpubmed-meshheading:9725389-...lld:pubmed
pubmed-article:9725389pubmed:meshHeadingpubmed-meshheading:9725389-...lld:pubmed
pubmed-article:9725389pubmed:meshHeadingpubmed-meshheading:9725389-...lld:pubmed
pubmed-article:9725389pubmed:meshHeadingpubmed-meshheading:9725389-...lld:pubmed
pubmed-article:9725389pubmed:meshHeadingpubmed-meshheading:9725389-...lld:pubmed
pubmed-article:9725389pubmed:meshHeadingpubmed-meshheading:9725389-...lld:pubmed
pubmed-article:9725389pubmed:meshHeadingpubmed-meshheading:9725389-...lld:pubmed
pubmed-article:9725389pubmed:meshHeadingpubmed-meshheading:9725389-...lld:pubmed
pubmed-article:9725389pubmed:meshHeadingpubmed-meshheading:9725389-...lld:pubmed
pubmed-article:9725389pubmed:meshHeadingpubmed-meshheading:9725389-...lld:pubmed
pubmed-article:9725389pubmed:meshHeadingpubmed-meshheading:9725389-...lld:pubmed
pubmed-article:9725389pubmed:year1998lld:pubmed
pubmed-article:9725389pubmed:articleTitleVivostat system autologous fibrin sealant: preliminary study in elective coronary bypass grafting.lld:pubmed
pubmed-article:9725389pubmed:affiliationDepartment of Cardiothoracic Surgery, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.lld:pubmed
pubmed-article:9725389pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9725389pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:9725389pubmed:publicationTypeRandomized Controlled Triallld:pubmed